FDA Import Refusal 721-2403023-9/2/2 — Glaxo Wellcome
The FDA refused shipment 721-2403023-9/2/2 from Glaxo Wellcome (Pakistan) on Jul 14, 2004. The refused product falls under Drugs and Biologics — NEOMYCIN SULFATE (AMINOGLYCOSIDES). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jul 14, 2004
- Country
- Pakistan
- Product Category
- Drugs and Biologics
- Product Code
- 56DBJ41 NEOMYCIN SULFATE (AMINOGLYCOSIDES)
- Charges
- 118,75